Genenta Science S.p.A.
GNTA
$4.25
$0.07721.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -5.80% | -11.87% | -17.22% | -10.33% | -5.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.74% | -23.09% | -28.70% | -10.56% | 9.99% |
| Operating Income | 16.74% | 23.09% | 28.70% | 10.56% | -9.99% |
| Income Before Tax | 23.43% | 26.78% | 29.84% | 0.43% | -43.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.43% | 26.78% | 29.84% | 0.43% | -43.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.43% | 26.78% | 29.84% | 0.43% | -43.59% |
| EBIT | 16.74% | 23.09% | 28.70% | 10.56% | -9.99% |
| EBITDA | 16.81% | 23.23% | 28.89% | 10.81% | -9.65% |
| EPS Basic | 23.68% | 26.94% | 29.90% | 0.47% | -43.60% |
| Normalized Basic EPS | 23.66% | 26.96% | 29.93% | 0.49% | -43.54% |
| EPS Diluted | 23.68% | 26.94% | 29.90% | 0.47% | -43.60% |
| Normalized Diluted EPS | 23.66% | 26.96% | 29.93% | 0.49% | -43.54% |
| Average Basic Shares Outstanding | 0.31% | 0.21% | 0.11% | 0.05% | 0.00% |
| Average Diluted Shares Outstanding | 0.31% | 0.21% | 0.11% | 0.05% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |